OncoAlert Colloquium Day 2: Lung cancer and MASCC

Teamwork in cancer care

Empathy in cancer care

Art and medicine

The only Journey is the one within

Dihydropyrimidine dehydrogenase polymorphisms knocking on the door

Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy for classic Hodgkin lymphoma

SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC

Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups

Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease

The RxPONDER trial and its impact on best clinical practice

WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine